Supplement analysis backed by scientific evidence · PT

← All supplements
Moderate evidenceWomen's health

Cranberry Extract

Cranberry products genuinely reduce recurrent urinary tract infections in otherwise healthy women and in children — roughly a 30% relative reduction — but they do nothing for elderly nursing-home residents or people with bladder-emptying problems, and they do not treat an active infection.

What the science says

  • Prevents recurrent UTIs in women Moderate evidence

    The 2023 Cochrane review pooled around 50 studies and nearly 9,000 participants and found cranberry products reduced the risk of recurrent symptomatic, culture-verified UTI by about 30% (RR roughly 0.70) in women with recurrent infections, with benefit also seen in children and in people after urological interventions. Certainty was rated moderate. Trials generally ran 6-12 months.

  • Prevents UTIs in the elderly or in people with neurogenic bladder Limited evidence

    The same Cochrane analysis found no benefit in elderly institutionalized residents, in pregnant women, or in people with bladder-emptying problems such as neurogenic bladder or indwelling catheters. This is an important boundary: the population where UTI burden is highest is the population where cranberry does not appear to work.

  • Higher proanthocyanidin doses work better Limited evidence

    A double-blind randomized trial directly compared a high-dose (2 × 37 mg PAC/day) against a low-dose (2 × 18.5 mg PAC/day) standardized cranberry proanthocyanidin extract in healthy women with recurrent UTI and found both reduced infections without a clear advantage for the higher dose. The commonly cited 36 mg PAC/day threshold is a reasonable target, but the dose-response curve above it is flat or unknown.

  • Treats an active urinary tract infection Limited evidence

    No trial supports cranberry as therapy for an established UTI. Delaying antibiotics for a symptomatic infection risks progression to pyelonephritis; cranberry is a prophylactic strategy only.

Dosage & safety

Studied doseAim for extracts standardized to about 36 mg/day of proanthocyanidins (measured by the BL-DMAC method), typically split into two doses; trials have used 18.5-37 mg PAC twice daily. Juice trials used roughly 240-300 mL of cranberry juice cocktail once or twice daily, which carries a substantial sugar load. Capsules with unstated PAC content are unreliable — PAC concentration varies enormously between products. Prophylaxis needs continuous use; effects stop when you stop.
SafetyWell tolerated; the usual issues are GI upset, reflux and diarrhea at high juice volumes. Cranberry is high in oxalate, and heavy juice intake has been linked to increased kidney stone risk in susceptible people. There are case reports and older warnings about raised INR with warfarin — monitor INR if you start or stop cranberry on warfarin, though controlled data suggest the interaction is modest. Juice products add significant sugar, a real consideration in diabetes. Not a substitute for antibiotics in an active infection, and not a substitute for evaluation if UTIs are frequent, febrile, or in men.

Scientific references

Where to buy

Emerald Laboratories, Cranberry Extract, 60 Vegetable Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Women's health